ANGPT2 and endothelial dysfunction: The potential of angiopoietin-2 as a biomarker for endothelial dysfunction and unfavorable outcome has been extensively investigated in septic populations [13–15], but has been restricted to in vitro models [3, 8] or the evaluation of plasma markers in cardiac surgery patients [9, 10, 16].